ArticleBMC bioinformatics2008
Novel computational methods for increasing PCR primer design effectiveness in directed sequencing.
Article in BMC bioinformatics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Article
- DeGenPrime provides robust primer design and optimization unlocking the biosphere.Bioinformatics advances · 2024Article
- Impact of SARS-CoV-2 Variants on the Analytical Sensitivity of rRT-PCR Assays.Journal of clinical microbiology · 2022Article
- Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2.Theranostics · 2020Review
- Laboratory Methods in Molecular Epidemiology: Viral Infections.Microbiology spectrum · 2018Review
- STITCHER 2.0: primer design for overlapping PCR applications.Scientific reports · 2017Article
- PrimerMapper: high throughput primer design and graphical assembly for PCR and SNP detection.Scientific reports · 2016Article
- Evolution of Influenza B Virus in Kuala Lumpur, Malaysia, between 1995 and 2008.Journal of virology · 2015Article
- PrimerView: high-throughput primer design and visualization.Source code for biology and medicine · 2015Article
- Wild-type measles viruses with non-standard genome lengths.PloS one · 2014Article
- Community differentiation of the cutaneous microbiota in psoriasis.Microbiome · 2013Article
- Analysis of whole genome sequences of 16 strains of rubella virus from the United States, 1961-2009.Virology journal · 2013Article
- PD5: a general purpose library for primer design software.PloS one · 2013Article
- Automated degenerate PCR primer design for high-throughput sequencing improves efficiency of viral sequencing.Virology journal · 2012Article
- Genomic analysis of 16 Colorado human NL63 coronaviruses identifies a new genotype, high sequence diversity in the N-terminal domain of the spike gene and evidence of recombination.The Journal of general virology · 2012Article
- A robust PCR primer design platform applied to the detection of Acidobacteria Group 1 in soil.Nucleic acids research · 2012Article
- Article
- Comparative whole genome sequencing reveals phenotypic tRNA gene duplication in spontaneous Schizosaccharomyces pombe La mutants.Nucleic acids research · 2011Article
- Phylogeography of the spring and fall waves of the H1N1/09 pandemic influenza virus in the United States.Journal of virology · 2011Article
- Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.PLoS pathogens · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolymerase chain reaction (PCR) is used in directed sequencing for the discovery of novel polymorphisms. As the first step in PCR directed sequencing, effective PCR primer design is crucial for obtaining high-quality sequence data for target regions. Since current computational primer design tools are not fully tuned with stable underlying laboratory protocols, researchers may still be forced to iteratively optimize protocols for failed amplifications after the primers have been ordered. Furthermore, potentially identifiable factors which contribute to PCR failures have yet to be elucidated. This inefficient approach to primer design is further intensified in a high-throughput laboratory, where hundreds of genes may be targeted in one experiment.
resultsWe have developed a fully integrated computational PCR primer design pipeline that plays a key role in our high-throughput directed sequencing pipeline. Investigators may specify target regions defined through a rich set of descriptors, such as Ensembl accessions and arbitrary genomic coordinates. Primer pairs are then selected computationally to produce a minimal amplicon set capable of tiling across the specified target regions. As part of the tiling process, primer pairs are computationally screened to meet the criteria for success with one of two PCR amplification protocols. In the process of improving our sequencing success rate, which currently exceeds 95% for exons, we have discovered novel and accurate computational methods capable of identifying primers that may lead to PCR failures. We reveal the laboratory protocols and their associated, empirically determined computational parameters, as well as describe the novel computational methods which may benefit others in future primer design research.
conclusionThe high-throughput PCR primer design pipeline has been very successful in providing the basis for high-quality directed sequencing results and for minimizing costs associated with labor and reprocessing. The modular architecture of the primer design software has made it possible to readily integrate additional primer critique tests based on iterative feedback from the laboratory. As a result, the primer design software, coupled with the laboratory protocols, serves as a powerful tool for low and high-throughput primer design to enable successful directed sequencing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.